RT Journal Article
T1 Clinical utility of a personalized and long-term monitoring device for Parkinson's disease in a real clinical practice setting: An expert opinion survey on STAT-ON (TM)
A1 Garcia, D. Santos
A1 Ariztegui, N. Lopez
A1 Cubo, E.
A1 Aragon, A. Vinagre
A1 Garcia-Ramos, R.
A1 Borrue, C.
A1 Fernandez-Pajarin, G.
A1 Caballol, N.
A1 Cabo, I.
A1 Barrios-Lopez, J. M.
A1 Vara, J. Hernandez
A1 Rivera, M. A. Avila
A1 Gasca-Salas, C.
A1 Escalante, S.
A1 de Lara, P. Manrique
A1 Noguera, R. Perez
A1 Sauco, M. Alvarez
A1 Sierra, M.
A1 Monje, M. H. G.
A1 Ferro, A. Sanchez
A1 Ponte, S. Novo
A1 Alonso-Frech, F.
A1 Macias-Garcia, D.
A1 Legarda, I.
A1 Rojo, A.
A1 Fernandez, I. Alvarez
A1 Buongiorno, M. T.
A1 Pastor, P.
A1 Ruiz, P. Garcia
K1 Device
K1 Fluctuations
K1 Holter
K1 Monitoring
K1 Motor complications
K1 Parkinson's disease
K1 Motor fluctuations
K1 Gait
K1 System
K1 Diary
AB Background: STAT-ON (TM) is an objective tool that registers ON-OFF fluctuations making possible to know the state of the patient at every moment of the day in normal life. Our aim was to analyze the opinion of different Parkinson's disease experts about the STAT-ON (TM) tool after using the device in a real clinical practice setting (RCPS).Methods: STAT-ON (TM) was provided by the Company Sense4Care to Spanish neurologists for using it in a RCPS. Each neurologist had the device for at least three months and could use it in PD patients at his/her own discretion. In February 2020, a survey with 30 questions was sent to all participants.Results: Two thirds of neurologists (53.8% females; mean age 44.9 +/- 9 years old) worked in a Movement Disorders Unit, the average experience in PD was 16 +/- 6.9 years, and 40.7% of them had previously used other devices. A total of 119 evaluations were performed in 114 patients (range 2-9 by neurologist; mean 4.5 +/- 2.3). STAT-ON (TM) was considered "quite" to "very useful" by 74% of the neurologists with an overall opinion of 6.9 +/- 1.7 (0, worst; 10, best). STAT-ON (TM) was considered better than diaries by 70.3% of neurologists and a useful tool for the identification of patients with advanced PD by 81.5%. Proper identification of freezing of gait episodes and falls were frequent limitations reported.Conclusion: STAT-ON (TM) could be a useful device for using in PD patients in clinical practice. (c) 2020 Sociedad Espanola de Neurologia. Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
PB Elsevier espana slu
SN 0213-4853
YR 2023
FD 2023-06-01
LK https://hdl.handle.net/10668/26270
UL https://hdl.handle.net/10668/26270
LA en
DS RISalud
RD Apr 8, 2025